Effect of tyrosine kinase inhibitors on renal handling of creatinine by MATE1.

about

Effect of tyrosine kinase inhibitors on renal handling of creatinine by MATE1.

Item

http://www.wikidata.org/entity/Q55300020

description

2018 nî lūn-bûn

@nan

2018年の論文

@ja

2018年学术文章

@wuu

2018年学术文章

@zh

2018年学术文章

@zh-cn

2018年学术文章

@zh-hans

2018年学术文章

@zh-my

2018年学术文章

@zh-sg

2018年學術文章

@yue

2018年學術文章

@zh-hant

name

Effect of tyrosine kinase inhibitors on renal handling of creatinine by MATE1.

@en

Effect of tyrosine kinase inhibitors on renal handling of creatinine by MATE1.

@nl

type

Item

label

Effect of tyrosine kinase inhibitors on renal handling of creatinine by MATE1.

@en

Effect of tyrosine kinase inhibitors on renal handling of creatinine by MATE1.

@nl

prefLabel

Effect of tyrosine kinase inhibitors on renal handling of creatinine by MATE1.

@en

Effect of tyrosine kinase inhibitors on renal handling of creatinine by MATE1.

@nl

P1476

Effect of tyrosine kinase inhibitors on renal handling of creatinine by MATE1

@en

P2093

Ikumi Tamai

http://www.w3.org/2001/XMLSchema#string

Natsumi Matsuoka

http://www.w3.org/2001/XMLSchema#string

Saki Omote

http://www.w3.org/2001/XMLSchema#string

P2860

New loci associated with kidney function and chronic kidney disease

Substrate specificity of MATE1 and MATE2-K, human multidrug and toxin extrusions/H(+)-organic cation antiporters

Differences in decline in GFR with age between males and females. Reference data on clearances of inulin and PAH in potential kidney donors.

Safety, pharmacokinetic, and antitumor activity of SU11248, a novel oral multitarget tyrosine kinase inhibitor, in patients with cancer.

Pazopanib after sunitinib failure in patients with metastatic renal cell carcinoma.

Contribution of the organic anion transporter OAT2 to the renal active tubular secretion of creatinine and mechanism for serum creatinine elevations caused by cobicistat

Nephrotic Syndrome and Acute Renal Failure Apparently Induced by Sunitinib

Identification and functional characterization of a new human kidney-specific H+/organic cation antiporter, kidney-specific multidrug and toxin extrusion 2.

Interactions of tyrosine kinase inhibitors with organic cation transporters and multidrug and toxic compound extrusion proteins

Rare mutations associating with serum creatinine and chronic kidney disease.

P304

9237

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1038/S41598-018-27672-Y

http://www.w3.org/2001/XMLSchema#string

P407

English

P433

http://www.w3.org/2001/XMLSchema#string

P478

http://www.w3.org/2001/XMLSchema#string

P50

Takeo Nakanishi

Hiroshi Arakawa

P577

2018-06-18T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

29915248

http://www.w3.org/2001/XMLSchema#string

P932

6006426

http://www.w3.org/2001/XMLSchema#string